Most patients with multiple sclerosis or a clini... [Arch Neurol. 2006] - PubMed

loading

Early treatment: PreCISe-ly what the patient needs. [J Neurol Sci. 2009]
Early treatment: PreCISe-ly what the patient needs.
Montalban X. J Neurol Sci. 2009 Dec; 287 Suppl 1:S2-6.
Not every patient with multiple sclerosis should be treated at time of diagnosis. [Arch Neurol. 2006]
Not every patient with multiple sclerosis should be treated at time of diagnosis.
Pittock SJ, Weinshenker BG, Noseworthy JH, Lucchinetti CF, Keegan M, Wingerchuk DM, Carter J, Shuster E, Rodriguez M. Arch Neurol. 2006 Apr; 63(4):611-4.
To treat, or not to treat: the therapeutic dilemma of idiopathic monosymptomatic demyelinating syndromes. [Arch Neurol. 2000]
To treat, or not to treat: the therapeutic dilemma of idiopathic monosymptomatic demyelinating syndromes.
Frohman EM, Racke M, van Den Noort S. Arch Neurol. 2000 Jul; 57(7):930-2.
Review New options for early treatment of multiple sclerosis. [J Neurol Sci. 2009]
Review New options for early treatment of multiple sclerosis.
Tintoré M. J Neurol Sci. 2009 Feb 1; 277 Suppl 1:S9-S11.
Review The definition of non-responder to multiple sclerosis treatment: neuroimaging markers. [Neurol Sci. 2008]
Review The definition of non-responder to multiple sclerosis treatment: neuroimaging markers.
Rovaris M. Neurol Sci. 2008 Sep; 29 Suppl 2:S222-4.

Establishing long-term efficacy in chronic disease: use of recursive partitioning and propensity score adjustment to estimate outcome in MS. [PLoS One. 2011]
Establishing long-term efficacy in chronic disease: use of recursive partitioning and propensity score adjustment to estimate outcome in MS.
Goodin DS, Jones J, Li D, Traboulsee A, Reder AT, Beckmann K, Konieczny A, Knappertz V, and the 16-Year Long-Term Follow-up Study Investigators. PLoS One. 2011; 6(11):e22444. Epub 2011 Nov 30.
When to initiate disease-modifying drugs for relapsing remitting multiple sclerosis in adults? [Mult Scler Int. 2011]
When to initiate disease-modifying drugs for relapsing remitting multiple sclerosis in adults?
Alkhawajah M, Oger J. Mult Scler Int. 2011; 2011:724871. Epub 2011 May 17.
Proteomic strategies in multiple sclerosis and its animal models. [Proteomics Clin Appl. 2007]
Proteomic strategies in multiple sclerosis and its animal models.
Elkabes S, Li H. Proteomics Clin Appl. 2007 Oct 16; 1(11):1393-1405.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Most patients with multiple sclerosis or a clinically isolated demyelinating syn...
Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.
Arch Neurol. 2006 Apr ;63(4):614-9.

PubMed
Supplementation of 1% L-glutamine to milk replacer does not overcome the growth ...
Supplementation of 1% L-glutamine to milk replacer does not overcome the growth depression in calves caused by soy protein concentrate.
J Dairy Sci. 2006 May ;89(5):1688-93.

PubMed
Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implication...
Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression.
Carcinogenesis. 2006 Oct ;27(10):1980-90. Epub 2006 Apr 10 .

PubMed
Constitutive receptor-independent low density lipoprotein uptake and cholesterol...
Constitutive receptor-independent low density lipoprotein uptake and cholesterol accumulation by macrophages differentiated from human monocytes with macrophage-colony-stimulating factor (M-CSF).
J Biol Chem. 2006 Jun 9 ;281(23):15757-62. Epub 2006 Apr 10 .

PubMed
Epidemiology studies in critical care.
Epidemiology studies in critical care.
Crit Care. 2006 ;10(2):136.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed